Glioblastoma multiforme: a glance at advanced therapies based on nanotechnology

AbstractGlioblastoma multiforme (GBM, grade IV) is the most common malignant and invasive central nervous system tumor with poor survival outcome. Various pathogenesis signatures such as genetic mu...